Does DAPTOMYCIN Cause Product use in unapproved indication? 654 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 654 reports of Product use in unapproved indication have been filed in association with DAPTOMYCIN (daptomycin). This represents 7.2% of all adverse event reports for DAPTOMYCIN.
654
Reports of Product use in unapproved indication with DAPTOMYCIN
7.2%
of all DAPTOMYCIN reports
29
Deaths
152
Hospitalizations
How Dangerous Is Product use in unapproved indication From DAPTOMYCIN?
Of the 654 reports, 29 (4.4%) resulted in death, 152 (23.2%) required hospitalization, and 11 (1.7%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPTOMYCIN. However, 654 reports have been filed with the FAERS database.
What Other Side Effects Does DAPTOMYCIN Cause?
Off label use (791)
Drug ineffective (658)
Eosinophilic pneumonia (575)
Acute kidney injury (501)
Blood creatine phosphokinase increased (461)
Pyrexia (447)
Eosinophilia (405)
Rhabdomyolysis (383)
Drug reaction with eosinophilia and systemic symptoms (307)
Chills (288)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which DAPTOMYCIN Alternatives Have Lower Product use in unapproved indication Risk?
DAPTOMYCIN vs DARATUMUMAB
DAPTOMYCIN vs DARATUMUMAB\HYALURONIDASE-FIHJ
DAPTOMYCIN vs DARBEPOETIN ALFA
DAPTOMYCIN vs DARIDOREXANT
DAPTOMYCIN vs DARIFENACIN HYDROBROMIDE